MASS SPECTROMETRY
AND IMMUNOTHERAPY
Immunopeptidomics. Proteomics. Bioinformatics.
PARADIGM SHIFTING SCIENCE
The field of immunopeptidomics will become as transformative as cancer genomics and will revolutionize cancer immunotherapy to improve patient care worldwide.
​
The Caron Lab moved to Yale University in 2024 to achieve this goal!
PASSION CAN CURE ANYTHING!
WHY WE DO IT
Immunopeptidomics is an emerging interdisciplinary science that has the potential to substantially influence various biomedical research fields, including:
-
T-cell immunology
-
Cancer immunotherapy
-
Vaccine development
-
Autoimmune research
-
Infectious disease research
-
Biomarker discovery
-
Personalized medicine
WHAT WE DO
-
Develop next-generation immunopeptidomics technologies
-
Develop a systems immunopeptidomics framework to challenge the current T-cell activation paradigm
-
Collaborate with clinical investigators and researchers in the field of autoimmunity, infectious diseases and cancer
HOW WE DO IT
-
We apply interdisciplinary methods from the fields of immunology, biochemistry, analytical chemistry, bioengineering, computational biology, artificial intelligence, and software engineering
-
We foster a culture that embraces inspiration from others
-
We love the Yale community and its outstanding research and collegial environment
-
We build the dream team
-
We have fun!
